Dextroamphetamine
DEXEDRINE, PROCENTRA, XELSTRYM, Zenzedi
Central Nervous System Stimulant
NADAC/unit
$0.4425
No Shortage
Tier 1: 57.1%
PA Req: 2.1%
11 Manufacturers
34 ANDAs
Dextroamphetamine treats ADHD and narcolepsy by increasing dopamine and norepinephrine activity.
vs. brand DEXEDRINE: Generic saves up to 96% per unit
Market Intelligence
2024-11-27 Class II Recall: Noven Pharmaceuticals Inc
2024-02-07 Class I Recall: Azurity Pharmaceuticals, Inc.
Generic Manufacturers
ACTAVIS ELIZABETH LLCAUROLIFE PHARMA LLCAVANTHI INCAZURITY PHARMACEUTICALS INCBARR LABORATORIES INCIMPAX LABORATORIES INCNOVEL LABORATORIES INCNOVEN PHARMACEUTICALS INCNUVO PHARMACEUTICAL INCPRASCO LLC DBA PRASCO LABORATORIESSPECGX LLCTRIS PHARMA INCWINDER LABORATOIRIES LLC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.